| abstract |
FIELD: medicine, pharmacology, biochemistry, pharmacy. n SUBSTANCE: invention relates to a pharmaceutical composition and industrial product comprising proteins Src and Yes of tyrosine kinase type together with a pharmaceutically acceptable carrier wherein at least one among protein Src and protein Yes represents active kinase and at least one among protein Scr and protein Yes represents inactive kinase, and to their amino acid sequences also. Invention provides the selective inhibition of tyrosine kinases activity, reduces damages or traumas associated with enhanced permeability of tissue vessels. n EFFECT: valuable medicinal properties of modulators. n 16 cl, 16 dwg, 14 ex |